ICD-10 diagnosis code

G13.2 Systemic atrophy primarily affecting central nervous system in myxoedemaE00.1E03.-

This page in Swedish

G13.2 is the ICD-10 code for Systemic atrophy primarily affecting central nervous system in myxoedemaE00.1E03.-. It is a four-character subcategory of G13 (Systemic atrophies primarily affecting central nervous system in diseases classified elsewhere), the most specific level in the WHO edition. It belongs to the block G10–G14 (Systemic atrophies primarily affecting the central nervous system) in Chapter VI, Diseases of the nervous system.

Code type
Subcategory (4 characters)
Chapter
VI · G00–G99
Classification
WHO ICD-10, 2019 version

G13.2 in national editions

Countries report with their own edition of ICD-10. Most keep the WHO code and add more specific codes beneath it.

NorwayICD-10-NO

G13.2Sekundær atrofi i sentralnervesystemet ved myksødem

DenmarkICD-10-DK

DG132Generel atrofi, som primært afficerer centralnervesystemet, ved myksødem

GermanyICD-10-GM

G13.2Systematrophie, vorwiegend das Zentralnervensystem betreffend, bei Myxödem

United StatesICD-10-CM

G13.2Systemic atrophy primarily affecting the central nervous system in myxedema

Based on the World Health Organization’s International Statistical Classification of Diseases and Related Health Problems, 10th revision (ICD-10), 2019 version, and the national editions published by each country’s health authority. This page is a reference, not coding advice; follow your national coding rules when you report.

Look up another code

Stop looking codes up by hand

Docdemic listens to the consultation, writes the note and suggests the diagnosis and procedure codes that fit it, each one checked against your country’s official code list.

Try Docdemic free